Urine LAM is used for diagnosis of?
**Core Concept**
Lymphangioleiomyomatosis (LAM) is a rare, progressive lung disease characterized by the proliferation of abnormal smooth muscle-like cells in the lungs, leading to cystic destruction of lung tissue. Urine LAM refers to the diagnosis of LAM through the detection of specific genetic mutations or proteins in the urine.
**Why the Correct Answer is Right**
The correct answer is related to the detection of TSC2 (tuberous sclerosis complex 2) gene mutations in the urine. LAM is often associated with mutations in the TSC2 gene, which is a tumor suppressor gene. The TSC2 gene is also associated with tuberous sclerosis complex (TSC), a genetic disorder that affects multiple organ systems. The detection of TSC2 mutations in the urine is a specific and sensitive test for diagnosing LAM.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because urine LAM is not used for the diagnosis of primary ciliary dyskinesia (PCD), which is a genetic disorder affecting the cilia in the respiratory tract.
**Option B:** This option is incorrect because urine LAM is not used for the diagnosis of cystic fibrosis, which is a genetic disorder affecting the secretory glands.
**Option C:** This option is incorrect because urine LAM is not used for the diagnosis of lymphoma, which is a type of cancer that affects the immune system.
**Clinical Pearl / High-Yield Fact**
The detection of TSC2 mutations in the urine is a specific and sensitive test for diagnosing LAM, and it is often used in conjunction with imaging studies and pulmonary function tests to confirm the diagnosis.
**Correct Answer: D. Tuberous Sclerosis Complex 2 (TSC2) gene mutations.**